Cancer breakthroughs and barriers in oncology R&D

October 23, 2023 • 11:30 AM - 1:30 PM ET
Virtual event

Endpoints is on the ground at ESMO this year and the lineup will be one to watch — what drugs in the cancer pipeline show promise? Which ones won’t make it past the goal line? Join us as we break down the highlights and readouts with our expert roundtable moderated by Endpoints journalists and more. Tune in online as our team reports from Madrid, breaking stories at one of the biggest oncology conferences of the year.

sponsored by
11:30 AM - 12:00 PM ET

Cancer's next decade

After a decade of patient breakthroughs leveraging technologies like immunotherapy, ADCs and targeted therapies, cancer R&D is staring down its next era. Our expert panel will look at how the R&D landscape has shifted, new attempts to go after cancer's “undruggable” targets and how the field is thinking about where the goalposts are in what remains a crowded space.

Charles Fuchs
Charles Fuchs

Senior Vice President - Global Head of Oncology and Hematology Product Development

Genentech and Roche
Christiana Bardon
Christiana Bardon

Co-Managing Partner

MPM BioImpact
Steve Wedge
Steve Wedge

Chief Scientific Officer, Therapeutic Innovation

Cancer Research Horizons
Amber Tong
Amber Tong

Senior Editor

Endpoints news
12:05 PM - 12:25 PM ET

Fireside chat with Jake Van Naarden

An in-depth discussion featuring Endpoints Associate Editor Kyle LaHucik and Jake Van Naarden, President of Loxo@Lilly.

Jake Van Naarden
Jake Van Naarden

President

Loxo@Lilly
Kyle LaHucik
Kyle LaHucik

Associate Editor

Endpoints News
12:30 PM - 1:00 PM ET

ESMO wrap

Our journalists review the biggest research, drug development and company news out of the ESMO conference.

Afsaneh Barzi
Afsaneh Barzi

Medical Oncologist

City of Hope cancer center
Xiuning Le
Xiuning Le

Assistant Professor of Thoracic/Head and Neck Medical Oncology

The University of Texas MD Anderson Cancer Center
Thomas Powles
Thomas Powles

Director

Barts Cancer Centre at St. Bartholomew’s Hospital
Kyle LaHucik
Kyle LaHucik

Associate editor

Endpoints News
Lei Lei Wu
Lei Lei Wu

News Reporter

Endpoints News
1:05 PM - 1:30 PM ET

Fireside chat

An in-depth discussion featuring Endpoints CEO Arsalan Arif and an industry leader — more to come.

Israel Lowy
Israel Lowy

Senior Vice President, Translational and Clinical Sciences, Oncology

Regeneron
Arsalan Arif
Arsalan Arif

Publisher & Founder

Endpoints News

Register now

No cost to register, subject to confirmation. By registering for this event, you accept that you may receive direct communication from the sponsor(s). If you are experiencing problems with your registration, please contact our support team.